85 related articles for article (PubMed ID: 9109381)
21. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
22. Cu2+ and Zn2+ inhibit nitric-oxide synthase through an interaction with the reductase domain.
Perry JM; Zhao Y; Marletta MA
J Biol Chem; 2000 May; 275(19):14070-6. PubMed ID: 10799481
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts.
Wolff DJ; Papoiu AD; Mialkowski K; Richardson CF; Schuster DI; Wilson SR
Arch Biochem Biophys; 2000 Jun; 378(2):216-23. PubMed ID: 10860539
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
25. Modulation of nitric-oxide synthase by nicotine.
Tonnessen BH; Severson SR; Hurt RD; Miller VM
J Pharmacol Exp Ther; 2000 Nov; 295(2):601-6. PubMed ID: 11046094
[TBL] [Abstract][Full Text] [Related]
26. A synthetic peptide corresponding to the putative dihydrofolate reductase domain of nitric oxide synthase inhibits uncoupled NADPH oxidation.
Mayer B; Pitters E; Pfeiffer S; Kukovetz WR; Schmidt K
Nitric Oxide; 1997 Feb; 1(1):50-5. PubMed ID: 9701044
[TBL] [Abstract][Full Text] [Related]
27. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.
Olken NM; Marletta MA
Biochemistry; 1993 Sep; 32(37):9677-85. PubMed ID: 7690590
[TBL] [Abstract][Full Text] [Related]
28. Possible involvement of tyrosine kinase activation in lipopolysaccharide-induced expression of Ca(2+)-insensitive but calmodulin-coupling nitric oxide synthase in rat glial cells.
Kitamura Y; Imaizumi R; Kitayama Y; Esumi H; Nomura Y
J Neurosci Res; 1996 Jan; 43(2):235-45. PubMed ID: 8820971
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
30. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide synthases: catalytic function and progress towards selective inhibition.
Mayer B; Andrew P
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jul; 358(1):127-33. PubMed ID: 9721014
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase activity in tissues of the bovine eye.
Geyer O; Podos SM; Mittag T
Graefes Arch Clin Exp Ophthalmol; 1997 Dec; 235(12):786-93. PubMed ID: 9439972
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501
[TBL] [Abstract][Full Text] [Related]
34. Autoinhibition of neuronal nitric oxide synthase: distinct effects of reactive nitrogen and oxygen species on enzyme activity.
Kotsonis P; Frey A; Fröhlich LG; Hofmann H; Reif A; Wink DA; Feelisch M; Schmidt HH
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):745-52. PubMed ID: 10359660
[TBL] [Abstract][Full Text] [Related]
35. The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents.
Wolff DJ; Gribin BJ
Arch Biochem Biophys; 1994 Jun; 311(2):300-6. PubMed ID: 7515613
[TBL] [Abstract][Full Text] [Related]
36. Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.
Mitchell JA; Kohlhaas KL; Sorrentino R; Warner TD; Murad F; Vane JR
Br J Pharmacol; 1993 May; 109(1):265-70. PubMed ID: 7684306
[TBL] [Abstract][Full Text] [Related]
37. Haloperidol inhibits neuronal nitric oxide synthase activity by preventing electron transfer.
Iwahashi K; Yoneyama H; Ohnishi T; Nakamura K; Miyatake R; Suwaki H; Hosokawa K; Ichikawa Y
Neuropsychobiology; 1996; 33(2):76-9. PubMed ID: 8927232
[TBL] [Abstract][Full Text] [Related]
38. Efficient formation of nitric oxide from selective oxidation of N-aryl N'-hydroxyguanidines by inducible nitric oxide synthase.
Renodon-Cornière A; Boucher JL; Dijols S; Stuehr DJ; Mansuy D
Biochemistry; 1999 Apr; 38(15):4663-8. PubMed ID: 10200153
[TBL] [Abstract][Full Text] [Related]
39. The natural product noformycin is an inhibitor of inducible-nitric oxide synthase.
Green BG; Chabin R; Grant SK
Biochem Biophys Res Commun; 1996 Aug; 225(2):621-6. PubMed ID: 8753809
[TBL] [Abstract][Full Text] [Related]
40. Possible involvement of neuronal nitric oxide synthase enzyme in early-phase isoflurane-induced hypotension in rats.
Ellenberger EA; Lucas HL; Mueller JL; Barrington PL; Chung E; Ohgami Y; Quock RM
Life Sci; 2004 Dec; 76(5):499-507. PubMed ID: 15556163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
